Low-grade inflammation is characterized by enhanced constitutive circulation of inflammatory mediators such as cytokines, e.g., interleukin 6 (IL6), tumor necrosis factor-alpha (TNFα), and acute-phase proteins [21, 22], in the absence of clinically defined infections. This evidence concerns the gene IL6 and infection.